Michael Barry. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » AgedAnticoagulants/adverse effectsAnticoagulants/pharmacologyDrug InteractionsFemaleFluorobenzenes/adverse effectsFluorobenzenes/pharmacologyHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effectsHydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacologyInternational Normalized RatioPyrimidines/adverse effectsPyrimidines/pharmacologyRhabdomyolysis/chemically inducedRosuvastatin CalciumSulfonamides/adverse effectsSulfonamides/pharmacologyWarfarin/adverse effectsWarfarin/pharmacology
Substances: See more » AnticoagulantsFluorobenzenesHydroxymethylglutaryl-CoA Reductase InhibitorsPyrimidinesSulfonamidesWarfarinRosuvastatin Calcium
Year: 2004 PMID: 14751711 DOI: 10.1016/S0140-6736(03)15396-2
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321